Sign up


Match Document Document Title
8557260 Composition comprising at least two different cycloalkylmethicones and use thereof  
A cosmetic composition includes comprising a blend of cycloalkylmethicones comprising at least two different cycloalkylmethicones having general formula I: where R1 is a hydrocarbon radical...
8557870 Methods of treatment utilizing topical emulsion-gel composition comprising diclofenac sodium  
The invention relates to methods for treating burns or inflammation utilizing beneficial pharmaceutical compositions comprising diclofenac sodium salt in unusually low amounts. The compositions...
8557230 Cosmetic compositions containing block copolymers, tackifiers and shine enhancing agents  
A cosmetic composition containing at least one block copolymer having a hard segment and a soft segment, at least one tackifier component, at least one solvent, or solvent mixture, at least one...
8557280 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Stable pharmaceutical composition and methods of using same
 
The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
8551522 Sustained-release formulation  
A sustained-release formulation is provided comprising a solid dispersion composition comprising a tricyclic compound or a pharmaceutically acceptable salt thereof in a mixture comprising a...
8551528 Diketopiperazine microparticles with defined specific surface areas  
Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a...
8551525 Bone graft materials and methods  
Compositions, materials, methods and kits for bone grafting are described. In some embodiments, a bone graft composition includes about 15% to about 20% by weight collagen, about 55% to about 70%...
8551542 Methods and compositions for increasing growth hormones  
Embodiments of the invention generally relate to methods and supplements for improving the health of human beings.
8551505 Compositions and methods for therapeutic delivery with frozen particles  
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at...
8551917 Use of prolines for improving growth and/or yield  
The present invention describes a composition including a mixture of L- and D-pyroglutamate stereoisomers in a ratio of L to D of from about 80:20 to about 97:3, and, a carrier medium for...
8551502 Process for producing poly(vinyl alcohol)-bacterial cellulose nanocomposite  
Hydrogel-bacterial cellulose nano-composite materials are created using a hydrogel and never dried bacterial cellulose fibers. Such materials are suitable for a broad range of soft tissue...
8551521 Stable pharmaceutical composition and methods of using same  
The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
8551507 Terpene glycosides and their combinations as solubilizing agents  
Several terpene glycosides (e.g., mogroside V, paenoiflorin, geniposide, rubusoside, rebaudioside A, steviol monoside and stevioside) were discovered to enhance the solubility of a number of...
8551503 Topical anti-inflammatory compositions comprising O/W emulsions containing pro-penetrating glycols  
Topically applicable compositions in the form of oil-in-water (O/W) emulsions contain a pro-penetrating system including at least one glycol and at least one additional pro-penetrating agent, a...
8551530 Nanoparticle isoflavone compositions and methods of making and using the same  
The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension...
8551506 Compositions and methods for administering compartmentalized frozen particles  
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at...
8551515 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Pharmacokinetics of S-adenosylmethionine formulations
 
Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved...
8551504 Topical anti-inflammatory compositions comprising O/W emulsions containing pro-penetrating glycols  
Topically applicable compositions in the form of oil-in-water emulsions contain a pro-penetrating system including at least one glycol and at least one additional pro-penetrating agent, a suitable...
8546325 Composition for improving membrane composition and functioning of cells  
It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises a) a...
8545856 Compositions and methods for delivery of frozen particle adhesives  
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at...
8545864 Hemostatic bone graft  
The present invention provides a hemostatic bone graft product and method. Hemostatic bone grafts may include demineralized bone matrix in combination with additives. In one embodiment, the graft...
8545832 Lipid depot formulations  
The present invention relates to pre-formulations comprising low viscosity, non-liquid crystalline, mixtures of: a) at least one neutral diacyl lipid and/or at least one tocopherol; b) at least one...
8546521 Method for fabricating nanoparticles  
Systems and methods are provided for filtering a fluid containing nanoparticles. The systems and methods generally include introducing a stream of the nanoparticle-containing fluid into a holding...
8545855 Compositions and methods for surface abrasion with frozen particles  
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at...
8545857 Compositions and methods for administering compartmentalized frozen particles  
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at...
8545830 Multi-functional polymeric materials and their uses  
Multifunctional polymers are disclosed having a smart segment and a biodegradable segment. Advantageously, the biodegradable segment includes a hydrophilic segment and a hydrophobic segment....
8545858 Porous calcium phosphate bone material  
Porous calcium phosphate implant compositions that approximate the chemical composition of natural bone mineral are provided. In addition to calcium phosphate, the compositions include an...
8541046 Process for the preparation of a canola protein isolate  
A novel canola protein isolate of predominantly 2S canola protein and having improved solubility properties, has an increased proportion of 2S canola protein and a decreased proportion of 7S canola...
8541764 Method of utilizing an implant for targeting external beam radiation  
A method of partial breast radiation therapy includes placing within a breast cavity a substantially radio-opaque implant constructed of biocompatible material, said substantially radio-opaque...
8541018 Palatable suspending vehicle for pharmaceutical ingredients  
The invention relates to a liquid vehicle that can be used to create suspensions and/or solutions of liquid or powdered medications. The vehicle is thixotropic and has improved stability and...
8541439 Formable aquatic coverings for preventing biofouling  
The instant invention describes an anti-biofouling structure for placement onto structures or surfaces that are exposed to aquatic environments. Embedded within the anti-biofouling structure are...
8541047 Polar antiseptic/antibacterial containing toothpick probes  
A toothpick probe molded of nylon 6 material and containing absorbed polar mouthwash antiseptic/antibacterial solution for probing between human teeth and probing of the gums holding the human...
8541019 Palatable ductile chewable veterinary composition  
The present invention is directed to palatable ductile chewable veterinary composition for oral administration. The composition is capable of killing endo-parasites and ecto-parasites and/or can be...
8535693 Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof  
Nanoemulsified topical formulation comprising curcumin, tetrahydroxycurcumin (BDMC) and curcuminoid either alone or in combinations in an amount of 0.001% to 50% together with one or more...
8535691 Perflurochemical treatment process and apparatus  
A subject is confined in a closed environment at an elevated pressure through which perfluorochemical fluid containing dissolved oxygen is circulated to treat disease or injury.
8535694 Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors  
The embodiments disclosed herein relate to ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for treating an ocular disease and/or...
8535692 Local anesthetic emulsion compositions and methods of making and using the same  
Local anesthetic emulsion compositions are provided. The local anesthetic emulsion compositions may include: an oily phase comprising a eutectic mixture of a local anesthetic and an acyclic amide;...
8535696 Treating eczema and/or psoriasis  
The treatment of humans or other mammals for eczema and/or psoriasis using dosage forms or compositions that include cetyl myristate alone or (in admixture or serially) both cetyl myristate and...
8535695 Pharmaceutical compositions and related methods of delivery  
The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt...
8529917 Micelle encapsulation of a combination of therapeutic agents  
The invention provides active agents, such as paclitaxel, rapamycin, or 17-DMAG, encapsulated by safe poly(ethylene glycol)-block-poly(lactic acid) (“PEG-b-PLA”) micelles. The compositions pro...
8529947 Alkaloid formulations  
There is provided an alkaloid formulation comprising the reaction product of one or more alkaloids with one or more phosphate derivatives of one or more electron transfer agents.
8530500 Stable pharmaceutical omeprazole formulation for oral administration  
The present invention is directed to a pharmaceutical solution or syrup formulation for oral administration comprising; omeprazole, a solubilizing agent, a sweetening agent, a flavoring agent, and...
8529915 (R)-(-)-1,2-propanediol compositions and methods  
Short-chain 2- to 3-carbon alcohols are used as solvents for cooling agents in the preparation of topical therapeutic and cosmetic formulations. Some of these alcohols, especially ethanol, inhibit...
8529953 Process for production of spherical microparticles comprising tamsulosin hydrochloride  
The present invention provides a method for producing spherical fine particles containing tamsulosin hydrochloride, the method includes the steps of: (1) mixing and stirring tamsulosin...
8529955 Methods of treatment using a gastric retained gabapentin dosage  
A method of treatment for epilepsy and other disease states is described, which comprises delivery of gabapentin in a gastric retained dosage form.
8529914 Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive  
A bioactive dose for delivering a bioactive agent to a mammal, includes a solid bioactive dosage unit containing at least one bioactive agent and a rapid release coating provided on at least one...
8529916 High concentration baclofen preparations  
Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for...
8530507 Use of levo-ornidazole in the preparation of anti-anaerobic bacteria infection drugs  
The use of levo-ornidazole in the preparation of medicine for preventing and treating the anti-anaerobic bacteria infection is provided. It is demonstrated that levo-ornidazole exhibits lower...
8524206 Aqueous polyamine-containing carrier systems for water-insoluble materials  
The present invention is drawn to a carrier composition containing: (a) at least one polyamine compound comprising at least two amino groups; (b) at least one nonionic surfactant; (c) at least one...
8524203 Sunscreen composite particles for UVA and UVB protection  
Sunscreen composite particles for UVA and UVB protection are described. The particles are substantially free of supplied UVB sunscreen and are prepared with a UVA sunscreen suitable to undergo...